Emma Betuel

Biotech Reporter, TechCrunch

Emma Betuel covered drugs and biotech at TechCrunch. She has also written about science, technology, and culture for Inverse, Future Human, Texas Monthly, Observer, DoubleBlind Magazine and others. She holds dual undergraduate degrees in history, and health and human biology from Brown University and a masters in journalism from Columbia University. Find her at emmakbetuel.com.

Emma Betuel

Latest from Emma Betuel

Before you can even think about building an algorithm to read an X-ray or interpret a blood smear, the machine has to know what’s what in an image. All of…

A newcomer to AI data labeling, Encord looks to ride a rising tidal wave

The positive impact alternative meat products — like plant-based meat or cultivated meat — can have on the environment is striking. In optimistic scenarios where we transition to from meat-laden…

Here’s Y Combinator’s answer to cultivated meat’s scaling problem

This week, Nvidia, a company best known for its high-powered graphic processing units (GPUs) debuted a platform for the development of AI-powered medical devices. The device, called Clara Holoscan MGX,…

Nvidia’s Clara Holoscan MGX means to bring high-powered AI to the doctor’s office

The stethoscope has come a long way from its humble beginnings in the 19th century. The regular acoustic type is still used every day, but it’s been joined by a…

Eko expands algorithmic heart problem detection and lands $30M Series C extension

Twenty years ago, getting a human genome sequenced was a billion-dollar, international project. Today, you can get your dog’s genome sequenced by the end of the month for a few…

Volta Labs grabs $20 million to address a growing genomics bottleneck

If you were to accidentally drop the eye sensor developed by Injectsense, you’d have little chance of finding it. Ariel Cao, the founder and CEO, admits as much. But once…

Injectsense collects $1.7M grant for its eye implant smaller than a grain of rice

Colossal, the company known for its mission to resurrect a woolly mammoth (or at least, an elephant with some very mammoth-like traits), is back with $60 million in Series A…

Colossal grabs $60 million Series A for moonshot mammoth project

In the past year, there’s been a lot of hype around biomanufacturing — from growing cell-based meat to microbe-powered medicine manufacturing. But none of synthetic biology’s darlings can exist without…

Stämm Biotech raises $17M for its next-generation, 3D printed bioreactor

It’s one thing to develop a medical algorithm, quite another to prove that it actually works. To do that, you need one crucial thing that’s hard to come by: medical…

‘I need evidence yesterday’: Gesund raises $2 million to provide algorithm-validating data

Sirona Medical, a company developing an “operating system” for digital radiology, has acquired Nines — a company that has developed FDA-cleared analysis and triage algorithms. This acquisition comes during a…

Sirona Medical acquires Nines’ AI algorithms to rebuild radiology’s IT from the ground up

Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio, an Israel-based startup that…

Scopio aims to turn hematology into remote work with $50M C round

Rating symptoms on a numerical scale seems easy, but it can be harder than it appears. How much did it hurt when you stubbed your toe? Was it a two…

Koneksa’s $45 million round could help make at-home clinical trials a reality

The next time your doorbell rings, it might be a DoorDash delivery, or one of a handful of startups all vying for grocery delivery supremacy. Or it might be a…

Getlabs will build out its at-home blood testing network with $20M Series A

The field scientists once jokingly called “blobography” has come a long way. Cryogenic electron microscopy was formerly known for delivering amorphous images of biomolecules. Now it has become one of…

Gandeeva Therapeutics raises $40m zoom in on biomolecules – and create new drugs in the process

Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as…

Startup Battlefield winner Cellino grabs $80M Series A

If there was ever a rubber-meets-road moment for six-year-old app Gale Healthcare Solutions, it’s probably right now.  Gale Healthcare Solutions, founded in 2016, matches nurses with available work shifts. A…

Gale Healthcare raises $60M to match nurses with empty shifts

A hot bowl of pad thai simmers in front of you. The taste and texture is exactly what you might expect from a quick takeout dinner, but it’s not just…

Faeth Therapeutics closes $20M seed to turn nutrition into a pillar of cancer treatment

Verana Health, a company focused on collecting and organizing troves of medical data, announced a $150 million Series E funding round on Friday. This round comes as the company sets…

Verana Health closes $150M round to glean more detail from electronic health records

It’s been a big two years for biotech investors. But if you ask Po Bronson, a partner at SOSV’s IndieBio, this trend was probably a long time coming.  “Often, the…

Meet the 13 startups in IndieBio’s SF cohort, and discover what about each swayed investors

Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How…

‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M

Kiddo, formally known as Good Parents Inc., announced a $16 million Series A round on Tuesday. Through a combination of wearables, parental coaching and telehealth, the company has its sights…

Kiddo picks up $16M for a kids’ wearable aimed at four chronic conditions

Before the pandemic forced remote work, school and research to the forefront, decentralized clinical trials were probably on the horizon. Now, they’re here in earnest.  This week, precision psychiatry startup…

How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression

Prellis Biologics, a company developing the tools to create 3D-printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has…

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

When COVID-19 closed down most of society in 2020, Kian Sadeghi, like many of his then-classmates at the University of Pennsylvania, found himself holed up in his bedroom. He prefers…

Nucleus Genomics announces $3.5M seed round for a fresh take on genetic tests

MFB Fertility, the creator of a suite of at-home pregnancy-related hormone tests, announced a $9.7 million Series A round this week. The round follows several milestones for the company, including…

Proov raises $9.7M Series A for at-home ovulation testing platform

When you shop for a holiday gift, you probably read at least one review. Garner Health’s bet is when you look for a doctor, you’ll want to do the same…

Garner Health raises $45M Series B for ‘totally objective’ doctor review service

In a field that ranges from text therapy and AI chat bots, to guided meditation, some mental health startups are pursuing a different niche: therapy for kids. And kids only. …

HelloHero raises $7.7M seed round for an online ‘healthcare system’ for kids’ therapy

Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the increasingly competitive space of…

Nabla Bio raises $11M for an “end-to-end” antibody design platform

U.K.-based digital therapy company ieso announced a $53 million Series B round on Tuesday. The round is the funding the company needs to move in a brand new direction: creating…

UK-based mental health provider ieso raises $53M armed with an ‘unprecedented’ data set

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines is touting…

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs